Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2022-11-27 to 2022-12-07
Current total value of award: $1126.6
Description: 8509549280!TYPHOID VI POLYSACC